ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2013

TIARP Attenuates Autoantibody-Mediated Arthritis Via the Suppression of Neutrophil Infiltration into the Joint

Asuka Inoue1, Isao Matsumoto1, Yuki Tanaka2, Naoto Umeda1, Hoshimi Kawaguchi1, Hiroshi Ebe1, Yoshihiro Matsumoto3 and Takayuki Sumida1, 1Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 2Department of Internal Medicine, University of Tsukuba, Tsukuba, Japan, 3Product Research Department, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Cell Migration, Chemokine Receptors, chemokines, inflammatory cytokines and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis II

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose:

TIARP (TNFα-induced adipose-related protein) is dominantly expressed in macrophages (Mφ), neutrophils (PMN) and fibroblast-like synoviocytes (FLS). Recently, we found that TIARP functions as a negative regulator in autoimmune arthritis through the suppression of IL-6 production, NF-κB, STAT3 signaling in Mφ, although the molecular mechanism of TIARP-expressing cells in arthritis remains uncertain. The purpose of this study is to elucidate the functional role of TIARP in the pathogenesis of arthritis, especially focusing on PMN and FLS.

Methods:

(1) K/BxN serum-transferred arthritis was induced to TIARP-/-or WT, then the ankle thickness was monitored. Mice were also treated with intravenous administration of anti-Gr1 Ab (for the depletion of PMN) or control Ab every other day after the induction of arthritis. (2) RNAs were extracted from TIARP-/-or WT PMN, subsequently compared by Gene chip. (3) The expression of CXCR1 and CXCR2 on PMN was analyzed, and the chemoattractant activity of TIARP-/- or WT PMN was tested by trans-well chemotaxis assays. (4) Using TIARP-/-or WT FLS, the expression of IL-6, TNFα and CXCL2 after TNFα stimulation were compared. (5) To verify the effect of CXCL2, we performed the chemotaxis assay of PMN by applying to the lower chamber with anti-CXCL2 Ab. (6) The production of IL-17, TNFa and IL-6 from PMN stimulated by immune-complex (IC) were measured by ELISA. (7) Anti-IL-6R Ab was administrated every other day after the induction of serum transferred arthritis.

Results:

(1) The severity of arthritis in TIARP-/- mice was markedly exacerbated, and the recruitment of PMN into the joint was significantly enhanced. TIARP-/-mice treated with anti-Gr1 Ab showed significantly reduced cellular infiltrate into the joint, and reduced synovial thickening. (2) Gene ontology analysis of up-regulated genes in TIARP-/-PMN demonstrated the enrichment of genes involved in chemotaxis. (3) The expression of CXCR1/2 was significantly higher in TIARP-/- PMN, and the recruitment capacity was enhanced. (4) The expressions of IL-6 and CXCL2 in TIARP-/- FLS were significantly higher than in WT, whereas RANKL, MMP3 and MMP9 were not different. (5) The numbers of migrated PMN were significantly decreased by the addition of anti-CXCL2 Ab. (6) The production of IL-17, TNFa and IL-6 were comparable between WT and TIARP-/-PMN. (7) Serum-transferred arthritis in TIARP-/- mice was attenuated by the blockade of IL-6R signaling, and recruitment of PMN into the joint of TIARP-/-mice was suppressed.

Conclusion:

TIARP might down-regulate the production of CXCL2 from FLS and the expression of CXCR1/2 in PMN, resulting in the protective ability of neutrophil migration in arthritic joints, probably via the inhibition of IL-6 signaling.


Disclosure: A. Inoue, None; I. Matsumoto, None; Y. Tanaka, None; N. Umeda, None; H. Kawaguchi, None; H. Ebe, None; Y. Matsumoto, None; T. Sumida, None.

To cite this abstract in AMA style:

Inoue A, Matsumoto I, Tanaka Y, Umeda N, Kawaguchi H, Ebe H, Matsumoto Y, Sumida T. TIARP Attenuates Autoantibody-Mediated Arthritis Via the Suppression of Neutrophil Infiltration into the Joint [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/tiarp-attenuates-autoantibody-mediated-arthritis-via-the-suppression-of-neutrophil-infiltration-into-the-joint/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tiarp-attenuates-autoantibody-mediated-arthritis-via-the-suppression-of-neutrophil-infiltration-into-the-joint/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology